Clinical Trials Directory

Trials / Conditions / Larynx Squamous Cell Carcinoma

Larynx Squamous Cell Carcinoma

6 registered clinical trials studyying Larynx Squamous Cell Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingProactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NCT07180901
Centre hospitalier de l'Université de Montréal (CHUM)N/A
RecruitingA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Canc
NCT07063212
Memorial Sloan Kettering Cancer CenterPhase 2
RecruitingImmune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
NCT06947668
University of Erlangen-Nürnberg Medical School—
RecruitingFirst Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
NCT04858269
Wake Forest University Health SciencesPhase 2
TerminatedActivity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Ne
NCT04445064
Cliniques universitaires Saint-Luc- Université Catholique de LouvainPhase 2
CompletedIRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
NCT03381183
H. Lee Moffitt Cancer Center and Research InstitutePhase 1